综合征诊断检测:感染病诊疗的新路径
本文综述多重分子检测等综合征诊断面板在常见感染病快速诊断中的潜在获益与实施考量,指出其可改善临床决策、优化实验室流程并促进抗菌药物管理,强调需临床微生物实验室与抗菌药物管理项目协作以最大化影响。
要点
- 综合征面板可快速诊断常见感染病,助力临床决策与抗菌药物合理使用。
- 部分临床实践指南已将综合征面板视为感染病诊断的变革性工具。
- 需临床微生物实验室与抗菌药物管理项目协作以最大化面板价值。
核心结论
- 综合征诊断面板若实施周密、解读审慎,有望通过改善临床决策、优化实验室流程和加强抗菌药物管理来改善患者结局。
研究设计与样本
- 本文为综述,讨论多种感染病综合征面板的潜在获益与考量,并强调临床微生物实验室与抗菌药物管理项目的协作。
主要发现
- 多重分子检测等先进微生物技术是常见感染病快速诊断的新方法。
- 部分临床实践指南已将综合征面板视为感染病诊断的变革性工具。
- 综合征面板的潜在获益包括改善临床决策、优化实验室工作流程和增强抗菌药物管理。
临床怎么用
- 实施综合征面板时应周密规划并审慎解读结果。
- 临床微生物实验室与抗菌药物管理项目应协作以最大化面板影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Advanced microbiology technologies such as multiplex molecular assays (i.e. syndromic diagnostic tests) are a novel approach to the rapid diagnosis of common infectious diseases. As the global burden of antimicrobial resistance continues to rise, the judicious use of antimicrobials is of utmost importance. Syndromic panels are now being recognized in some clinical practice guidelines as a 'game-changer' in the diagnosis of infectious diseases. These syndromic panels, if implemented thoughtfully and interpreted carefully, have the potential to improve patient outcomes through improved clinical decision making, optimized laboratory workflow, and enhanced antimicrobial stewardship. This paper reviews the potential benefits of and considerations regarding various infectious diseases syndromic panels, and highlights how to maximize impact through collaboration between clinical microbiology laboratory and antimicrobial stewardship programmes.
引用
- Dumkow LE, Worden LJ, Rao SN, et al. Syndromic diagnostic testing: a new way to approach patient care in the treatment of infectious diseases. J Antimicrob Chemother. 2021. PMID: 34555157. doi:10.1093/jac/dkab245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。